Skip to main content
ARAY
NASDAQ Industrial Applications And Services

Accuray Seeks Stockholder Approval for $55M Recapitalization, Reverse Split, and Massive Dilution

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$0.28
Mkt Cap
$33.441M
52W Low
$0.22
52W High
$2.1
52W Position info
27% above low
Off High info
87% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

ARAY sits 27% above its 52-week low of $0.22 on light trading volume (0.3× avg).

Summary

Accuray seeks stockholder approval for a $55M recapitalization, reverse stock split, and authorized share increase to avoid default and regain Nasdaq compliance.


Key Events · Financing and Capital Events · ARAY

  • Recapitalization Terms

    Accuray will issue 55,000 shares of Series A Preferred Stock for $55 million: $15 million in cash and $40 million in debt conversion. The preferred stock converts into 110 million common shares at $0.50 per share.

  • Massive Dilution

    Conversion of preferred stock and exercise of 15.3 million warrants at $0.01 per share would increase outstanding shares from approximately 119.4 million to over 244 million, diluting existing holders by more than 100%.

  • Reverse Stock Split

    A reverse split of 1-for-15 to 1-for-40 is proposed to raise the stock price above $1.00 and regain Nasdaq compliance. The exact ratio will be determined by the Board.

  • Authorized Share Increase

    Authorized common shares would increase from 200 million to 400 million to accommodate the conversion of preferred stock.


Analysis · ARAY · Industrial Applications And Services

Accuray is asking stockholders to approve a $55 million recapitalization that will convert $40 million of debt into preferred stock and raise $15 million in cash. The deal includes a reverse stock split of 1-for-15 to 1-for-40 to regain Nasdaq compliance, and an increase in authorized shares from 200 million to 400 million. If approved, the preferred stock converts into 110 million common shares at $0.50 per share, and warrants for 15.3 million shares at $0.01 per share are issued. This will cause substantial dilution to existing holders, but the alternative is a $15 million fee and continued debt burden. The special meeting is set for October 6, 2026.

At the time of this filing, ARAY was trading at $0.28 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $33.4M. The 52-week trading range was $0.22 to $2.10. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ARAY - Latest Insights

ARAY
Jul 31, 2026, 7:00 AM EDT
Filing Type: S-3
Importance Score:
7
Price at Filing: $0.283
Real-time Price: $0.280 info
Change: -$0.0030 (-1%) info
Market Cap: $33.441M info
ARAY
Jul 29, 2026, 6:26 PM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $0.2355
Real-time Price: $0.280 info
Change: +$0.0445 (+19%) info
Market Cap: $33.441M info
ARAY
Jul 29, 2026, 5:25 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.2355
Real-time Price: $0.280 info
Change: +$0.0445 (+19%) info
Market Cap: $33.441M info
ARAY
Jun 04, 2026, 4:02 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.3655
Real-time Price: $0.280 info
Change: -$0.0855 (-23%) info
Market Cap: $33.441M info
ARAY
May 22, 2026, 3:57 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $0.3077
Real-time Price: $0.280 info
Change: -$0.0277 (-9%) info
Market Cap: $33.441M info